CYTEK BIOSCIENCES INC (CTKB) Earnings History & Surprises

NASDAQ:CTKBUS23285D1090

Current stock price

4.01 USD
+0.01 (+0.25%)
At close:
4.01 USD
0 (0%)
After Hours:

CTKB Earnings overview

Past quarterly earnings results for CYTEK BIOSCIENCES INC (CTKB), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).

Earnings Snapshot

Next Earnings Date

Upcoming
Release Date
May 6, 2026
Period
Q1 / 2026
EPS Estimate
-$0.10
Revenue Estimate
45.463M

Last Reported

Most Recent
Release Date
Feb 26, 2026
Period
Q4 / 2025
EPS Reported
-$0.04
EPS Surprise
1.96%
Revenue Surprise
6.53%

Beat Rate

Last 8 Quarters
44%
EPS and Revenue beats vs estimates

Quarterly Earnings Historical Results

EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.

QuarterEPSEPS EstEPS SurpriseEPS Q2QRevenueRevenue EstRevenue SurpriseRevenue Q2Q
Q4 2025 -0.04 -0.04 1.96% -157.14% 62.141M 58.331M 6.53% 8.12%
Q3 2025 -0.04 -0.05 25.30% -500.00% 52.293M 52.518M -0.43% 1.54%
Q2 2025 -0.04 -0.07 43.98% 50.00% 45.602M 47.271M -3.53% -2.18%
Q1 2025 -0.09 -0.05 -96.08% -80.00% 41.457M 43.516M -4.73% -7.59%
Q4 2024 0.07 0.05 31.98% 75.00% 57.476M 60.571M -5.11% -1.30%
Q3 2024 0.01 -0.02 165.36% 1,100.00% 51.5M 51.71M -0.41% 7.29%
Q2 2024 -0.08 -0.03 -161.44% -900.00% 46.617M 50.517M -7.72% -6.19%
Q1 2024 -0.05 -0.04 -22.55% - 44.86M 44.458M 0.90% 20.96%
Q4 2023 0.04 0.00 1,077.65% -33.33% 58.233M 57.714M 0.90% 20.47%
Q3 2023 0.00 0.03 -103.27% -102.50% 48M 56.585M -15.17% 18.58%
Q2 2023 0.01 0.03 -67.32% -66.67% 49.693M 46.627M 6.58% 23.74%
Q1 2023 0.00 0.03 -100.00% -100.00% 37.088M 48.089M -22.88% 5.78%
Q4 2022 0.06 0.05 26.04% 100.00% 48.34M 51.225M -5.63% 24.30%
Q3 2022 0.04 0.02 96.08% 100.00% 40.48M 44.154M -8.32% 17.74%
Q2 2022 0.03 0.02 76.44% - 40.16M 40.422M -0.65% 32.06%
Q1 2022 0.01 -0.01 296.08% - 35.06M 33.158M 5.74% 44.46%
Q4 2021 0.03 0.03 17.65% - 38.89M 37.148M 4.69% -
Q3 2021 0.02 0.02 -15.95% - 34.38M 34.053M 0.96% -
Q2 2021 0.00 0.02 -100.00% - 30.41M 28.846M 5.42% -
Q1 2021 - - 24.27M - 34.91%
Q4 2020 - - - -
Q1 2020 - - 17.99M - -

Notes

  • EPS and Revenue values are non-GAAP when available, otherwise GAAP.
  • Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
  • Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
  • Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.

Earnings Q2Q Performance Trends

EPS Historical Q2Q growth and Acceleration

CTKB EPS Q2Q GrowthCTKB EPS Q2Q GrowthEPS Q2Q Growth Q3/22 Q1/23 Q3/23 Q2/24 Q4/24 Q2/25 Q4/25 Q2/26 Q4/26 Q2/27 Q4/27 Q2/28 0 500 -500 1K

Revenue Historical Q2Q growth and Acceleration

CTKB Revenue Q2Q GrowthCTKB Revenue Q2Q GrowthRevenue Q2Q Growth Q1/21 Q2/22 Q4/22 Q2/23 Q4/23 Q2/24 Q4/24 Q2/25 Q4/25 Q2/26 Q4/26 Q2/27 Q4/27 Q2/28 0 10 20 30 40

Surprise distribution (Last 4 Quarters)

EPS beat statistics

EPS beat (4)
3
Average EPS beat (4)
-6.21%
Max EPS beat (4)
43.98%
Min EPS beat (4)
-96.08%

Revenue beat statistics

Revenue beat (4)
1
Average Revenue beat (4)
-0.54%
Max Revenue beat (4)
6.53%
Min Revenue beat (4)
-4.73%

Analysis

In the last 4 quarters, CTKB has beaten EPS estimates in 3 out of 4 releases
CTKB has beaten revenue estimates in 1 out of the last 4 releases
In the last 4 quarters, CTKB reported -6.2% below the EPS estimates on average.
In the last 4 quarters, CTKB reported -0.5% below the revenue estimates on average.

CYTEK BIOSCIENCES INC / CTKB Earnings FAQ

When did CYTEK BIOSCIENCES INC (CTKB) report earnings last quarter?

CYTEK BIOSCIENCES INC (CTKB) last reported earnings on 2/26/2026.

Did CTKB stock beat earnings estimates in the most recent quarter?

CYTEK BIOSCIENCES INC (CTKB) beat EPS estimates and beat revenue estimates in the most recent quarter.

How often does CYTEK BIOSCIENCES INC (CTKB) beat earnings estimates?

In the last 4 quarters, CYTEK BIOSCIENCES INC (CTKB) has beaten EPS estimates in 3 out of 4 releases.